Risk Factors for Bleeding Complications after Endoscopic Variceal Ligation Therapy

Zusammenfassung

Hintergrund: Ösophagusvarizenblutungen sind eine gefürchtete Komplikation der portalen Hypertension. Die endoskopische Gummibandligatur (ÖVL) stellt die Therapie der Wahl zur Behandlung der akuten Varizenblutung dar und wird auch zur Primär- und Sekundärprophylaxe von Varizenblutungen angewandt. Postinterventionell besteht das Risiko einer Re-Blutung. Risikofaktoren für Blutungskomplikationen nach ÖVL sind bisher wenig und nur an kleinen Patientenkollektiven untersucht. Methodik: Wir analysierten retrospektiv die Daten von Patienten, bei denen Ligaturbehandlungen durchgeführt wurden. Es wurde eine Vielzahl klinischer, laborchemischer und endoskopischer Daten analysiert. Ergebnisse: 255 Patienten und 387 Ligatursitzungen wurden in die Analyse eingeschlossen. Patienten mit Blutungskomplikation hatten im Vergleich eine eingeschränkte Leberfunktion gemessen an höherem Child-Pugh-Score (10,5 vs. 8, p = 0,002), niedrigerem Serum-Albumingehalt (26,5 vs. 31,9 [g/L], p = 0,0001) und niedrigerem Quick (46,5 vs. 70 [%], p = 0,0001). Bakterielle Infektionen traten signifikant häufiger bei Patienten mit postinterventioneller Blutung auf, Leukozyten als Entzündungsparameter waren ebenfalls signifikant erhöht (9,5 vs. 6,5 [× 10⁹ /L], p = 0,030). Die Herzfrequenz war bei Patienten mit Blutungsereignis im Vergleich höher (80 vs. 72 [Schläge/min], p = 0,017), außerdem zeigten sich Hämoglobin- (5,9 vs. 6,4 [mmol/L], p = 0,028) und Hämatokrit-Werte (0,280 vs. 0,314; p = 0,031) erniedrigt. Des Weiteren erlitten jüngere Patienten häufiger Nachblutungen (52,5 vs. 58 [Jahre], p = 0,012). Schlussfolgerung: Zur Kalkulation des Nachblutungsrisikos stehen einfach zu erhebende klinische Parameter zur Verfügung, die rasch eine Aussage über das Blutungsrisiko geben können.

Abstract

Background: Bleeding from esophageal varices is a severe complication of portal hypertension. Endoscopic band ligation (EBL) is the treatment of choice for acute variceal bleeding. It is also performed for primary and secondary prophylaxis of bleeding from esophageal varices. After EBL, patients are at risk of postinterventional bleeding; the risk factors for this complication are poorly evaluated. Methods: We retrospectively analyzed data from patients who underwent EBL. We evaluated clinical data, laboratory and endoscopic findings. Results: 255 patients with 387 ligation sessions were included in the analysis. Patients with bleeding complications had a significantly higher severity of liver disease as measured by a higher Child-Pugh score (10.5 vs. 8, p = 0.002), lower albumin (26.5 vs. 31.9 [g/L], p = 0.0001) and lower prothrombin activity (46.5 vs. 70 [%], p = 0.0001). The incidence of bacterial infection was significantly higher in patients with postinterventional bleeding. As well, the white blood cell count was significantly higher in the bleeding group (9.5 vs. 6.5 [× 10⁹ /L], p = 0.030). In patients with bleeding events we observed an elevated heart rate compared to those without this complication (80 vs. 72 [bpm], p = 0.017). Furthermore, we found a lower hemoglobin level (5.9 vs. 6.4 [mmol/L], p = 0.028) and a lower hematocrit (0.280 vs. 0.314, p = 0.031) in the bleeding group. Younger patients suffered more often from postinterventional bleeding (52.5 vs. 58 [years], p = 0.012). Conclusion: There are clinical data which can be ascertained easily in order to reflect the risk of bleeding complications after EBL.

Ösophagusvarizen - endoskopische Gummibandligatur (ÖVL) - Varizenblutungen - Leberzirrhose - portale Hypertension - Komplikationen - Risikofaktoren - Nachblutungen

esophageal varices - endoscopic band ligation (EBL) - variceal bleeding - liver cirrhosis - portal hypertension - complications - risk factors - rebleeding

References

• 1 Carbonell N, Pauwels A, Serfaty L et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.  Hepatology. 2004;  40 652-659
• 2 Chalasani N, Kahi C, Francois F et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study.  Am J Gastroenterol. 2003;  98 653-659
• 3 D’Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.  Hepatology. 2003;  38 599-612
• 4 Grace N D. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.  Am J Gastroenterol. 1997;  92 1081-1091
• 5 Stiegmann G V, Goff J S, Michaletz-Onody P A et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.  N Engl J Med. 1992;  326 1527-1532
• 6 Baroncini D, Milandri G L, Borioni D et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.  Endoscopy. 1997;  29 235-240
• 7 Garcia-Pagan J C, Bosch J. Endoscopic band ligation in the treatment of portal hypertension.  Nat Clin Pract Gastroenterol Hepatol. 2005;  2 526-535
• 8 Gimson A E, Ramage J K, Panos M Z et al. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices.  Lancet. 1993;  342 391-394
• 9 Hou M C, Lin H C, Kuo B I et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial.  Hepatology. 1995;  21 1517-1522
• 10 Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis.  Ann Intern Med. 1995;  123 280-287
• 11 Laine L, el-Newihi H M, Migikovsky B et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices.  Ann Intern Med. 1993;  119 1-7
• 12 Lo G H, Lai K H, Chang C F et al. Endoscopic injection sclerotherapy vs. endoscopic variceal ligation in arresting acute variceal bleeding for patients with advanced hepatocellular carcinoma.  J Hepatol. 1994;  21 1048-1052
• 13 Lo G H, Lai K H, Cheng J S et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices.  Hepatology. 1995;  22 466-471
• 14 Sarin S K, Govil A, Jain A K et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence.  J Hepatol. 1997;  26 826-832
• 15 Villanueva C, Piqueras M, Aracil C et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding.  J Hepatol. 2006;  45 560-567
• 16 Lo G H, Lai K H, Cheng J S et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices.  Hepatology. 1997;  25 1101-1104
• 17 Franchis de R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.  J Hepatol. 2005;  43 167-176
• 18 Imperiale T F, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding.  Hepatology. 2001;  33 802-807
• 19 Sarin S K, Wadhawan M, Agarwal S R et al. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding.  Am J Gastroenterol. 2005;  100 797-804
• 20 De BK, Ghoshal U C, Das T et al. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial.  J Gastroenterol Hepatol. 1999;  14 220-224
• 21 Harewood G C, Baron T H, Song L M. Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding.  J Gastroenterol Hepatol. 2006;  21 237-241
• 22 Lay C S, Tsai Y T, Teg C Y et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices.  Hepatology. 1997;  25 1346-1350
• 23 Lo G H, Lai K H, Cheng J S et al. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial.  J Hepatol. 1999;  31 451-456
• 24 Sarin S K, Lamba G S, Kumar M et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.  N Engl J Med. 1999;  340 988-993
• 25 Bambha K, Kim W R, Pedersen R et al. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis.  Gut. 2008;  57 814-820
• 26 Dombal F T, Clarke J R, Clamp S E et al. Prognostic factors in upper G. I. bleeding.  Endoscopy. 1986;  18 (Suppl 2) 6-10
• 27 Mihas A A, Sanyal A J. Recurrent variceal bleeding despite endoscopic and medical therapy.  Gastroenterology. 2004;  127 621-629
• 28 Yang M T, Chen H S, Lee H C et al. Risk factors and survival of early bleeding after esophageal variceal ligation.  Hepatogastroenterology. 2007;  54 1705-1709
• 29 Wipassakornwarawuth de S, Opasoh M, Ammaranun K et al. Rate and associated risk factors of rebleeding after endoscopic variceal band ligation.  J Med Assoc Thai. 2002;  85 698-702
• 30 Lee S W, Lee T Y, Chang C S. Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage.  Dig Dis Sci. 2009;  54 1128-1134
• 31 Pugh R N, Murray-Lyon I M, Dawson J L et al. Transection of the oesophagus for bleeding oesophageal varices.  Br J Surg. 1973;  60 646-649
• 32 Petrasch F, Grothaus J, Mossner J et al. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis.  BMC Gastroenterology. 2010;  10 5
• 33 Perneger T V. What’s wrong with Bonferroni adjustments.  BMJ. 1998;  316 1236-1238
• 34 Shaffer J P. Multiple hypothesis-testing.  Annu Rev Psychol. 1995;  46 561-584
• 35 D’Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding.  Baillieres Clin Gastroenterol. 1997;  11 243-256
• 36 Bosch J, Abraldes J G, Groszmann R. Current management of portal hypertension.  J Hepatol. 2003;  38 (Suppl 1) S54-S68
• 37 Sharara A I, Rockey D C. Gastroesophageal variceal hemorrhage.  N Engl J Med. 2001;  345 669-681
• 38 Akhtar N, Zuberi B F, Hasan S R et al. Determination of correlation of adjusted blood requirement index with outcome in patients presenting with acute variceal bleeding.  World J Gastroenterol. 2009;  15 2372-2375
• 39 Bernard B, Cadranel J F, Valla D et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.  Gastroenterology. 1995;  108 1828-1834
• 40 Goulis J, Armonis A, Patch D et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.  Hepatology. 1998;  27 1207-1212
• 41 Bernard B, Grange J D, Khac E N et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.  Hepatology. 1999;  29 1655-1661
• 42 Blaise M, Pateron D, Trinchet J C et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage.  Hepatology. 1994;  20 34-38
• 43 Hou M C, Lin H C, Liu T T et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.  Hepatology. 2004;  39 746-753
• 44 Pauwels A, Mostefa-Kara N, Debenes B et al. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.  Hepatology. 1996;  24 802-806
• 45 Rimola A, Bory F, Teres J et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage.  Hepatology. 1985;  5 463-467
• 46 Soriano G, Guarner C, Tomas A et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage.  Gastroenterology. 1992;  103 1267-1272
• 47 Hsieh W J, Lin H C, Hwang S J et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.  Am J Gastroenterol. 1998;  93 962-966
• 48 Bleichner G, Boulanger R, Squara P et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage.  Br J Surg. 1986;  73 724-726
• 49 Rimola A, Soto R, Bory F et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.  Hepatology. 1984;  4 53-58
• 50 Burroughs A K, Triantos C K, O’Beirne J et al. Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis.  Nat Clin Pract Gastroenterol Hepatol. 2009;  6 72-73
• 51 Fong T V, Hung F C, Chiu K W et al. Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients.  Hepatogastroenterology. 2008;  55 1055-1058
• 52 Lo G H, Lin C Y, Lai K H et al. Endoscopic injection sclerotherapy versus conservative treatment for patients with unresectable hepatocellular carcinoma and bleeding esophageal varices.  Gastrointest Endosc. 1991;  37 161-164